Cargando…

Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()

Vaccination in pregnancy is an effective strategy to prevent serious infections in mothers and their infants. Safety of this strategy is of principal importance to all stakeholders. As the number of studies assessing safety of vaccines in pregnancy increases, the need to ensure consistent collection...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Christine E., Munoz, Flor M., Kochhar, Sonali, Vergnano, Stefania, Cutland, Clare L., Steinhoff, Mark, Black, Steven, Heininger, Ulrich, Bonhoeffer, Jan, Heath, Paul T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139802/
https://www.ncbi.nlm.nih.gov/pubmed/27793485
http://dx.doi.org/10.1016/j.vaccine.2016.07.007
_version_ 1782472308710965248
author Jones, Christine E.
Munoz, Flor M.
Kochhar, Sonali
Vergnano, Stefania
Cutland, Clare L.
Steinhoff, Mark
Black, Steven
Heininger, Ulrich
Bonhoeffer, Jan
Heath, Paul T.
author_facet Jones, Christine E.
Munoz, Flor M.
Kochhar, Sonali
Vergnano, Stefania
Cutland, Clare L.
Steinhoff, Mark
Black, Steven
Heininger, Ulrich
Bonhoeffer, Jan
Heath, Paul T.
author_sort Jones, Christine E.
collection PubMed
description Vaccination in pregnancy is an effective strategy to prevent serious infections in mothers and their infants. Safety of this strategy is of principal importance to all stakeholders. As the number of studies assessing safety of vaccines in pregnancy increases, the need to ensure consistent collection and reporting of critical data to allow comparisons and data pooling becomes more important. The Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project aims to improve data collection and create a shared understanding of maternal, fetal and neonatal outcomes in order to progress the global agenda for vaccination in pregnancy. The guidance in this document has been developed to harmonize the data collected in case report forms used for safety monitoring in clinical trials of vaccination in pregnant women. Data to be collected is prioritized to allow applicability in diverse research settings, including low and middle-income countries. Standardized data will enable the research community to have a common base upon which to conduct meta-analyses, strengthening the applicability of outcomes to different settings.
format Online
Article
Text
id pubmed-5139802
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-51398022016-12-12 Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy() Jones, Christine E. Munoz, Flor M. Kochhar, Sonali Vergnano, Stefania Cutland, Clare L. Steinhoff, Mark Black, Steven Heininger, Ulrich Bonhoeffer, Jan Heath, Paul T. Vaccine Article Vaccination in pregnancy is an effective strategy to prevent serious infections in mothers and their infants. Safety of this strategy is of principal importance to all stakeholders. As the number of studies assessing safety of vaccines in pregnancy increases, the need to ensure consistent collection and reporting of critical data to allow comparisons and data pooling becomes more important. The Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) project aims to improve data collection and create a shared understanding of maternal, fetal and neonatal outcomes in order to progress the global agenda for vaccination in pregnancy. The guidance in this document has been developed to harmonize the data collected in case report forms used for safety monitoring in clinical trials of vaccination in pregnant women. Data to be collected is prioritized to allow applicability in diverse research settings, including low and middle-income countries. Standardized data will enable the research community to have a common base upon which to conduct meta-analyses, strengthening the applicability of outcomes to different settings. Elsevier Science 2016-12-01 /pmc/articles/PMC5139802/ /pubmed/27793485 http://dx.doi.org/10.1016/j.vaccine.2016.07.007 Text en © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jones, Christine E.
Munoz, Flor M.
Kochhar, Sonali
Vergnano, Stefania
Cutland, Clare L.
Steinhoff, Mark
Black, Steven
Heininger, Ulrich
Bonhoeffer, Jan
Heath, Paul T.
Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
title Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
title_full Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
title_fullStr Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
title_full_unstemmed Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
title_short Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
title_sort guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139802/
https://www.ncbi.nlm.nih.gov/pubmed/27793485
http://dx.doi.org/10.1016/j.vaccine.2016.07.007
work_keys_str_mv AT joneschristinee guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT munozflorm guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT kochharsonali guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT vergnanostefania guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT cutlandclarel guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT steinhoffmark guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT blacksteven guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT heiningerulrich guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT bonhoefferjan guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy
AT heathpault guidanceforthecollectionofcasereportformvariablestoassesssafetyinclinicaltrialsofvaccinesinpregnancy